In bid to save cash, Grail says it will cut 350 jobs and focus on multi-cancer test
The cancer diagnostics company Grail announced Tuesday that it plans to cut 30% of its workforce to reduce expenses, just weeks after being spun out …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.